Sensus Healthcare Analyst Targets Diverge Amid 2026 Expectations Shift

Wednesday, Mar 11, 2026 12:44 pm ET1min read
SRTS--

Sensus Healthcare's analyst narrative has shifted with one price target at $7.50 and another at $6. Alliance Global is bullish on the SRT-100/Vision platform and potential reimbursement changes in 2026, while Maxim is cautious citing recent quarterly weakness and customer concentration. The company plans to introduce Sensus Link, a cloud-based software and connectivity solution, in a phased commercial rollout starting in 2026.

Sensus Healthcare Analyst Targets Diverge Amid 2026 Expectations Shift

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet